Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
Track all the latest updates and news of Sotac Pharmaceuticals IPO.
July 2, 2024 1:43:05 PM
E mcure Pharmaceuticals is set to open its initial public offering (IPO) for subscription on Wednesday, July 3. Before the listing, the company's shares were trading at a premium of Rs 265 in the ...
Published by : Times Now on MSNJuly 2, 2024 10:11:22 AM
Emcure Pharmaceuticals IPO set to start tomorrow estimated to bring in ?127.87 crore for Namita Thapar, a Shark Tank India investor. Thapar to sell around 12.68 lakh shares through the offer for sale ...
Published by : Live Mint on MSNJune 7, 2024 2:30:00 PM
Rapport�s public proposal was swiftly followed by one from radiopharma-focused Telix Pharmaceuticals, an Australian biotech that announced plans for a $200 million U.S. IPO on June 5.
Published by : FierceBiotechJune 5, 2024 2:28:00 PM
Australian radiopharmaceuticals biotech Telix Pharmaceuticals is targeting a ... Telix anticipates the net proceeds from the IPO to be around $183 million, or $211 million if the underwriters ...
Published by : FierceBiotechJune 29, 2024 3:30:00 AM
Emcure Pharmaceuticals IPO price band has been set in the range of ?960 to ?1,008 per equity share of the face value of ?10. (https://www.emcure.com/) The Pune ...
Published by : MintJune 29, 2024 8:04:00 PM
Emcure Pharmaceuticals IPO: The initial share sale will be available for public subscription during July 3-5 and the bidding for anchor investors will open for a day on July 2, the company announced.
Published by : Zee BusinessJune 28, 2024 6:47:00 PM
Pune-based Emcure Pharmaceuticals is gearing up to launch ... band of ?960-1008 per share for its initial public offering (IPO), which will open for subscription from July 3 to July 5.
Published by : India InfolineJune 28, 2024 12:58:00 AM
Pune-based Emcure Pharmaceuticals is set to launch its maiden public issue for subscription on July 3. The price band will be announced by June 28. The IPO, which is a mix of fresh issuance of ...
Published by : moneycontrol.comJune 11, 2024 6:23:00 PM
Telix Pharmaceuticals (TLX) has filed proposed terms to raise $202 million from the sale of its common stock in an IPO, according to an amended SEC registration statement. The company is a ...
Published by : Seeking AlphaJune 21, 2024 10:38:00 PM
Maharashtra-based Emcure Pharmaceuticals has secured approval from the Securities and Exchange Board of India (SEBI) to proceed with its initial public offering (IPO). According to sources ...
Published by : India InfolineJune 21, 2024 3:41:00 AM
a Pune-based company and a powerhouse in the pharmaceutical industry, has received approval from the market regulator SEBI to launch its much anticipated Initial Public Offering (IPO). According ...
Published by : The Free Press JournalJune 20, 2024 10:33:00 PM
According to the latest DRHP filed last week, Emcure Pharmaceuticals IPO would consist of a fresh issuance of equity shares worth ?800 crore and an Offer of Sale (OFS) of 1.36 crore equity ...
Published by : MintThe IPO Shares of Sotac Pharmaceuticals Limited IPO are proposed to list on Thursday, April 13, 2023 at NSE SME. The public issue of Sotac Pharmaceuticals IPO was opened on Mar 29, 2023 and closed for subscription on Apr 3, 2023. Sotac Pharmaceuticals IPO Listing Date and Information:
| Listing Date | Thursday, April 13, 2023 |
| BSE Script Code | |
| NSE Symbol | SOTAC |
| Listing In | |
| ISIN | INE0O2D01012 |
| Issue Price | ₹111 Per Equity Share |
| Face Value | ₹10 Per Equity Share |
The allotment status of Sotac Pharmaceuticals Limited IPO is now available online. The public issue of Sotac Pharmaceuticals IPO was open on Mar 29, 2023 and closed for subscription on Apr 3, 2023. The equity shares of the company to be list at NSE SME
.
Sotac Pharmaceuticals Limited is entering in the capital market with an IPO of 3,000,000 Equity Shares of Rs 10 aggregating up to Rs 33.30 Crore. The price for the issue has been set at Rs 105 - Rs 111 Per Equity Share.
Incorporated in 2015, Sotac Pharmaceuticals Limited is a part of the SOTAC group, based in Gujarat. The company is in the business of manufacturing pharmaceutical products for different marketers on a loan license or contract manufacturing basis. The company's business is majorly on principle to principle basis with different marketers.
The issue opens on Mar 29, 2023 and closes for subscription on Apr 3, 2023. The equity shares of the company to be list at NSE SME.
The issue of Sotac Pharmaceuticals Limited opens on Mar 29, 2023 and closes for subscription on Apr 3, 2023. The equity shares of the company to be list at NSE SME. The price for the issue has been set at Rs 105 - Rs 111 Per Equity Share.
The Sotac Pharmaceuticals IPO is proposed to open on March 29, 2023. The IPO application ends on April 3, 2023.
Retail investors can apply in the retail or non-institutional investor category from March 29, 2023 to April 3, 2023. The Sotac Pharmaceuticals IPO can be applied online through Net Bank (ASBA method) or the stock broker (UPI method).
The Sotac Pharmaceuticals IPO will open for subscription on March 29, 2023. The public issue will close on April 3, 2023.
Useful Articles
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
|
RHP
